LINC01022

Across TCGA pan-cancer cohorts, LINC01022 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated LINC01022 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher LINC01022 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01022 expression acts as an unfavorable survival marker, although some lineages such as PRAD show a favorable association.

LUSC, KIRC, and ACC are the cancer types where LINC01022 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
KIRC	OS	Tertile	All	0.545	0.647	.044	21	view →
ACC	OS	Tertile	All	0.147	0.685	.018	21	view →
PRAD	DFS	Tertile	All	0.968	0.895	.003	12	view →
GBM	OS	Tertile	All	0.179	0.429	.035	9	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

LINC01022–LUSC (OS)

Open the LUSC breakdown →